AbbVie Inc. (ABBV) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on the tape, currently trading at $119.75, up from yesterday’s close by 1.23%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
AbbVie Inc. (ABBV) currently trades with a market capitalization of $191.12 Billion. That value represents a market adjusting for revenues that have been growing by 13.88 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of $8.47 Billion over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.78 on a per share basis this quarter. Perhaps, that suggests something about why 0.08% of the outstanding share supply is held by institutional investors.
As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, AbbVie Inc. recorded a 52-week high of $125.86. It is now trading 6.11% off that level. The stock is trading $110.82 its 50-day moving average by -8.93%. The stock carved out a 52-week low down at $63.12.
In recent action, AbbVie Inc. (ABBV) has made a move of +6.99% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.04% with $1.60 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ABBV.